BMC Nephrology (Jan 2022)

Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure

  • Soo Kun Lim,
  • Bak Leong Goh,
  • Ravindran Visvanathan,
  • Su Hyun Kim,
  • Jin Seok Jeon,
  • Sung Gyun Kim,
  • Jae Hyun Chang,
  • Chun Soo Lim,
  • Zaki Morad

DOI
https://doi.org/10.1186/s12882-021-02651-0
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 1

Abstract

Read online

No abstracts available.